Mangalam Drugs and Organics Q2 Results 2025 Highlights: Net Profit Falls 373.09% & Revenue Down 38.03% YoY

November 26, 2025
Posted by: sachet
Category: News

Click and Sign Up to Get Live Updates on Q2 Results

Mangalam Drugs and Organics Q2 Results FY26: During Q2 FY26, Mangalam Drugs and Organics’ profit decreased 373.09% YoY, while revenue decreased by 38.03% YoY. The company posted robust numbers, with Q2 PAT at -₹7.35 crores and revenue at ₹49.54 crores. Mangalam Drugs and Organics announced its Q2 results on 21st November 2025.

Table of Contents

Mangalam Drugs and Organics Q2 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

Particulars	Quarter Ended
Particulars	30-09-2025	30-09-2024
Revenue from Operations	₹49.54	₹79.94
Profit Before Tax (PBT)	-₹2.81	₹8.84
Profit After Tax (PAT)	-₹7.35	₹2.69

(Figures in crores)

Mangalam Drugs and Organics Q2 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

Particulars	Quarter Ended
Particulars	30-09-2025	30-09-2024
Revenue from Operations	₹49.54	₹79.94
Profit Before Tax (PBT)	-₹2.80	₹8.83
Profit After Tax (PAT)	-₹7.25	₹2.69

(Figures in crores)

Mangalam Drugs and Organics Q2 Results FY26 Highlights (Q2 FY26 vs FY25)

Mangalam Drugs and Organics clocked Q2 FY26 consolidated revenue of ₹8.08 crores vs ₹270.51 crores.
On the profit front, Mangalam Drugs and Organics earned a consolidated PAT of -₹0.35 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹26.33 crore.
According to the consolidated figures, Mangalam Drugs and Organics’s quarterly PAT decreased by 101.34% YoY, while revenue decreased by 97.01%.
Mangalam Drugs and Organics clocked Q2 FY26 standalone revenue of ₹8.08 crores vs ₹80.33 crores.
On the profit front, Mangalam Drugs and Organics earned a standalone PAT of -₹0.35 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹6.15 crore.
According to the standalone figures, Mangalam Drugs and Organics’s quarterly PAT decreased by 369.87% YoY, while revenue decreased by 38.03%.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Mangalam Drugs and Organics Share Price Performance

On the opening bell on 26th November 2025, Mangalam Drugs and Organics shares opened at ₹32.68 per share. However, the initial gains have since eroded, and Mangalam Drugs and Organics shares are currently trading at ₹32.60 per share, lower than the opening price.

Considering the long-term performance, Mangalam Drugs and Organics shares have yielded returns of approximately -60.26% over the past 6 months and -69.32% over the past 1 year. Over the maximum timeframe, Mangalam Drugs and Organics shares delivered a return of -4.44% to investors.

What Analysts Expect Post Q2 Results?

Following Mangalam Drugs and Organics’s robust Q2 results, analysts expect its share price to rise. According to analysts, Mangalam Drugs and Organics’s share price is expected to reach ₹56.70 per share in the coming year; however, in a downturn, it could fall to ₹21.60 per share. However, one must ignore stock market volatility and invest in Mangalam Drugs and Organics’s shares after thorough research.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.